Healthcare professionals, retailers, and members of the public are encouraged to report any suspected unsafe, falsified, or illegal products through the appropriate reporting channels.
However, when combined with insulin or sulfonylureas, hypoglycemia risk increases, and dose adjustments of these concomitant medications may be necessary
Case Study 2: Comparative Efficacy of Multi-Agonists Semaglutide Single agonist: Targets GLP-1 to boost insulin secretion and reduce appetite
Emerging evidence indicates the therapeutic potential of ferulic acid in attenuating secondary brain injury following TBI (Li Y
Before bariatric surgery: Multi-disciplinary evaluation required including psychiatric screening, nutritional assessment, and medical clearance